Trigeminal Otonomik Baş Ağrıları

Özet

Referanslar

Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia – diagnosis and treatment. Cephalalgia. Haziran 2017;37(7):648-57.

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. Ocak 2018;38(1):1-211.

San-Juan D, Velez-Jimenez K, Hoffmann J, Martínez-Mayorga AP, Melo-Carrillo A, Rodríguez-Leyva I, vd. Cluster headache: an update on clinical features, epidemiology, pathophysiology, diagnosis, and treatment. Front Pain Res. 08 Mart 2024;5:1373528.

Fischera M, Marziniak M, Gralow I, Evers S. The Incidence and Prevalence of Cluster Headache: A Me- ta-Analysis of Population-Based Studies. Cephalalgia. Haziran 2008;28(6):614-8.

Waung MW, Taylor A, Qualmann KJ, Burish MJ. Family History of Cluster Headache: A Systematic Review. JAMA Neurol. 01 Temmuz 2020;77(7):887.

Rozen TD, Fishman RS. Cluster Headache in the United States of America: Demographics, Clinical Chara- cteristics, Triggers, Suicidality, and Personal Burden*. Headache. Ocak 2012;52(1):99-113.

Burish MJ, Pearson SM, Shapiro RE, Zhang W, Schor LI. Cluster headache is one of the most intensely pa- inful human conditions: Results from the International Cluster Headache Questionnaire. Headache. Ocak 2021;61(1):117-24.

Meyer EL, Laurell K, Artto V, Bendtsen L, Linde M, Kallela M, vd. Lateralization in cluster headache: a Nordic multicenter study. J Headache Pain. Ağustos 2009;10(4):259-63.

Wei DY, Goadsby PJ. Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster heada- che attacks. Cephalalgia. Temmuz 2021;41(8):913-33.

Buture A, Ahmed F, Dikomitis L, Boland JW. Systematic literature review on the delays in the diagnosis and misdiagnosis of cluster headache. Neurol Sci. Ocak 2019;40(1):25-39.

Burish M. Cluster Headache, SUNCT, and SUNA. CONTINUUM: Lifelong Learning in Neurology. Nisan 2024;30(2):391-410.

on behalf of EHF committee, Mitsikostas DD, Ashina M, Craven A, Diener HC, Goadsby PJ, vd. Europe- an headache federation consensus on technical investigation for primary headache disorders. J Headache Pain. Aralık 2015;17(1):5.

Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: Implications for hea- dache disorders. Annals of Neurology. Temmuz 2013;74(1):145-8.

Csati A. Calcitonin gene-related peptide and its receptor components in the human sphenopalatine gang- lion — Interaction with the sensory system. BRAIN RESEARCH.

Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, vd. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial. JAMA Neurol. 01 Ekim 2018;75(10):1187.

De Coo IF, Wilbrink LA, Haan J. Symptomatic Trigeminal Autonomic Cephalalgias. Curr Pain Headache Rep. Ağustos 2015;19(8):39.

Cittadini E, Matharu MS. Symptomatic Trigeminal Autonomic Cephalalgias. The Neurologist. Kasım 2009;15(6):305-12.

Steinberg A, Frederiksen SD, Blixt FW, Warfvinge K, Edvinsson L. Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets. J Headache Pain. Aralık 2016;17(1):78.

Laburthe M, Couvineau A, Tan V. Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology. Peptides. Eylül 2007;28(9):1631-9.

Dickson L, Finlayson K. VPAC and PAC receptors: From ligands to function. Pharmacology & Therapeutics. Mart 2009;121(3):294-316.

Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides. Nisan 2014;48(2):53-64.

Tuka B, Szabó N, Tóth E, Kincses ZT, Párdutz Á, Szok D, vd. Release of PACAP-38 in episodic cluster headache patients – an exploratory study. J Headache Pain. Aralık 2016;17(1):69.

Holland PR, Goadsby PJ. Cluster headache, hypothalamus, and orexin. Current Science Inc. Nisan 2009;13(2):147-54.

Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. Ağustos 2018;19(8):453-69.

Möller M, Haji AA, Hoffmann J, May A. Peripheral provocation of cranial autonomic symptoms is not sufficient to trigger cluster headache attacks. Cephalalgia. Temmuz 2018;38(8):1498-502.

Winsvold BS, Harder AVE, Ran C, Chalmer MA, Dalmasso MC, Ferkingstad E, vd. Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor. Annals of Neurology. Ekim 2023;94(4):713-26.

Medrea I, Christie S, Tepper SJ, Thavorn K, Hutton B. Network meta-analysis of therapies for cluster hea- dache: Effects of acute therapies for episodic and chronic cluster. Headache. Nisan 2022;62(4):482-511.

May A, Evers S, Goadsby PJ, Leone M, Manzoni GC, Pascual J, vd. European Academy of Neurology gui- delines on the treatment of cluster headache. Euro J of Neurology. Ekim 2023;30(10):2955-79.

Oude Nijhuis JC, Haane DY, Koehler PJ. A review of the current and potential oxygen delivery systems and techniques utilized in cluster headache attacks. Cephalalgia. Eylül 2016;36(10):970-9.

Markley HG. Topical agents in the treatment of cluster headache. Current Science Inc. Nisan 2003;7(2):139- 43.

Villar-Martínez MD, Puledda F, Goadsby PJ. Recent Advances in the Management of Cluster Headache. Curr Treat Options Neurol [Internet]. Aralık 2020 [a.yer 16 Temmuz 2025];22(12). Erişim adresi: http:// link.springer.com/10.1007/s11940-020-00655-z

Wilbrink LA, De Coo IF, Doesborg PGG, Mulleners WM, Teernstra OPM, Bartels EC, vd. Safety and ef- ficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headac- he (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial. The Lancet Neurology. Temmuz 2021;20(7):515-25.

Fontaine D, Christophe Sol J, Raoul S, Fabre N, Geraud G, Magne C, vd. Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation. Cephalalgia. Temmuz 2011;31(10):1101-5.

Schor LI, Pearson SM, Shapiro RE, Zhang W, Miao H, Burish MJ. Cluster headache epidemiology including pediatric onset, sex, and ICHD criteria: Results from the International Cluster Headache Questionnaire. Headache. Kasım 2021;61(10):1511-20.

Manzoni GC, Taga A, Russo M, Torelli P. Age of onset of episodic and chronic cluster headache – a review of a large case series from a single headache centre. J Headache Pain. Aralık 2016;17(1):44.

VanderPluym J. Cluster Headache: Special Considerations for Treatment of Female Patients of Reproduc- tive Age and Pediatric Patients. Curr Neurol Neurosci Rep. Ocak 2016;16(1):5.

Goadsby PJ. Indomethacin-Responsive Headache Disorders. CONTINUUM: Lifelong Learning in Neuro- logy. Nisan 2024;30(2):488-97.

Mauritz MD, Enninger A, Wamsler C, Wager J, Zernikow B. Long-Term Outcome of Indomethacin Treat- ment in Pediatric Patients with Paroxysmal Hemicrania—A Case Series. Children. 03 Şubat 2021;8(2):101.

Sjaastad O, Bakketeig LS. The rare, unilateral headaches. Vågå study of headache epidemiology. J Headache Pain. Şubat 2007;8(1):19-27.

Cohen A, Matharu M, Goadsby P. Paroxysmal Hemicrania in a Family. Cephalalgia. Nisan 2006;26(4):486- 8.

Bahra A. Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment. Cephalalgia. Kasım 2023;43(11):03331024231214239.

Tarantino S, Vollono C, Capuano A, Vigevano F, Valeriani M. Chronic paroxysmal hemicrania in paediat- ric age: report of two cases. J Headache Pain. Nisan 2011;12(2):263-7.

Cheung S ngai, Oliveira R, Goadsby PJ. Melatonin in hemicrania continua and paroxysmal hemicrania. Cephalalgia. Mart 2024;44(3):03331024231226196.

Kamourieh S, Lagrata S, Matharu MS. Non-invasive vagus nerve stimulation is beneficial in chronic pa- roxysmal hemicrania. J Neurol Neurosurg Psychiatry. Eylül 2019;90(9):1072-4.

Groenke BR, Daline IH, Nixdorf DR. SUNCT/SUNA: Case series presenting in an orofacial pain clinic. Cephalalgia. Mayıs 2021;41(6):665-76.

Williams MH, Broadley SA. SUNCT and SUNA: Clinical features and medical treatment. Journal of Clini- cal Neuroscience. Mayıs 2008;15(5):526-34.

Chitsantikul P, Becker WJ. SUNCT, SUNA and pituitary tumors: Clinical characteristics and treatment. Cephalalgia. Şubat 2013;33(3):160-70.

Pomeroy JL, Nahas SJ. SUNCT/SUNA: A Review. Curr Pain Headache Rep. Ağustos 2015;19(8):38.

Cohen A. Short-Lasting Unilateral Neuralgiform Headache Attacks with Conjunctival Injection and Tea- ring. 2007;

Matharu M, Cohen A, Goadsby P. SUNCT Syndrome Responsive to Intravenous Lidocaine. Cephalalgia. Kasım 2004;24(11):985-92.

Al-Khazali HM, Christensen RH, Lambru G, Dodick DW, Ashina H. Hemicrania Continua: An Update. Curr Pain Headache Rep. Ekim 2023;27(10):543-50.

Cittadini E, Goadsby PJ. Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain. 01 Temmuz 2010;133(7):1973-86.

Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RS, Goadsby PJ. Posterior Hypothalamic and Brainstem Activation in Hemicrania Continua. Headache. Eylül 2004;44(8):747-61.

Baraldi C, Pellesi L, Guerzoni S, Cainazzo MM, Pini LA. Therapeutical approaches to paroxysmal hemicra- nia, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal. J Headache Pain [Internet]. Aralık 2017 [a.yer 08 Temmuz 2025];18(1). Erişim adresi: https://thejournalof- headacheandpain.biomedcentral.com/articles/10.1186/s10194-017-0777-3

Pareja J, Caminero A, Franco E, Casado J, Pascual J, Del Río MS. Dose, Efficacy and Tolerability of Long- Term Indomethacin Treatment of Chronic Paroxysmal Hemicrania and Hemicrania Continua. Cephalal- gia. Kasım 2001;21(9):906-10.

Peres MFP, Silberstein SD. Hemicrania Continua Responds to Cyclooxygenase-2 Inhibitors. Headache. Haziran 2002;42(6):530-1.

Rozen TD. How Effective Is Melatonin as a Preventive Treatment for Hemicrania Continua? A Clinic-Ba- sed Study. Headache. Mart 2015;55(3):430-6.

Miller S, Correia F, Lagrata S, Matharu MS. OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients. J Headache Pain [Internet]. Aralık 2015 [a.yer 08 Temmuz 2025];16(1). Erişim adresi: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-015-0502-z

Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua respon- ding to topiramate: Two case reports. Clinical Neurology and Neurosurgery. Ocak 2008;110(1):88-91.

Spears RC. Is gabapentin an effective treatment choice for hemicrania continua? J Headache Pain. Ağustos 2009;10(4):271-5.

Trimboli M, Al-Kaisy A, Andreou AP, Murphy M, Lambru G. Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experience. Cephalalgia. Haziran 2018;38(7):1276-85.

Yayınlanan

17 Temmuz 2026

Lisans

Lisans